Actively Recruiting
Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms Treated With Radiotherapy at the Sant'Orsola Polyclinic in Bologna
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-14
3000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are collecting data on radiation treatment for uterine neoplasms, including endometrial and cervical cancers. The study aims to understand how tumor response and possible side effects relate to radiation doses, treatment techniques, and combinations with other therapies. By analyzing patient and disease characteristics, the study seeks to identify patterns that may help predict and prevent radiation-related toxicities in the future. This observational study gathers information from patients treated at the Radiotherapy Unit of the Sant'Orsola Polyclinic, including those diagnosed and treated since January 1, 2000. The data covers various treatment settings, dosages, fractionation schedules, and techniques used in radiotherapy, alone or combined with other therapies. Both retrospective and prospective data collection phases are included, covering treatments up to December 15, 2030. Participants provide information on tumor response, local disease recurrence, and survival during follow-up visits up to 12 months after treatment. Researchers also monitor acute and late toxicities, retreatments, and overall patient outcomes. The study involves around 5000 patients, without direct intervention or risk to participants, focusing solely on data collection to improve future care for uterine neoplasms.
CONDITIONS
Brief Title
Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients aged 18 years or older
- New or previous diagnosis of malignant uterine neoplasm starting from 01/01/2000
- Treated at the Radiotherapy Unit of the Sant'Orsola Polyclinic
- Willing to provide informed consent
You will not qualify if you...
- Patients with malignant uterine neoplasm who choose not to undergo radiation treatment at the Radiotherapy Unit of the Sant'Orsola Polyclinic
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From treatment start to up to 12 months follow-up
Participants who undergo routine care are observed to collect data about their radiotherapy treatment and outcomes related to uterine neoplasms.
Visits as per routine clinical care and follow-up schedules
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
Research Team
A
Alessio Giuseppe Morganti, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here